Ranbaxy taking 'stringent steps' to end US FDA ban
India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.
Sep 21, 2013
0
0